Further Information:
The Health Products Regulatory Authority has been notified of a shortage of the following products:
- Alprazolam 0.25mg Tablet – PA0711/140/001
- Doxatan 4mg Prolonged Release Tablet – PA0126/202/004
- Drynol 20mg Tablet – PA0865/018/001
- Megace 160mg Tablet – PA1696/002/001
- Oxynorm Liquid 1mg/1ml Oral Solution – PA1688/006/002
- Suprax 200mg Film Coated Tablet – PA0540/016/002
- Vepesid 100mg Capsule – PA2255/004/002
The following shortage has been resolved and supply has resumed to the Irish market:
- Alkeran 50mg Powder and Solvent for Solution for Infusion – PA1691/004/001
- Azactam 1g Powder for Solution for Injection or Infusion – PA0002/052/002
- Azactam 2g Powder for Solution for Injection or Infusion – PA0002/052/003
- Noradrenaline 1:1000 Concentrate for Solution for Infusion – PA0822/219/001
- Perdamel 0.5mg Film Coated Tablet – PA0126/169/002
- Perindopril Tosilate / Amlodipine Teva 5mg/10mg Tablet – PA0749/197/002
- Solpadol Effervescent 500mg/30mg Tablet – PA0540/159/003
- Zineryt 40mg + 12mg Powder & Solvent for Cutaneous Solution – PA0046/065/001
Please see the shortages section of the HPRA website for further information.
The HPRA will be sending weekly updates concerning medicinal product shortages. However, the above webpage will be updated in real time.